Benitec Biopharma Inc. (BNTC)
CIK 1808898 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Benitec Biopharma Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Jun 30, 2026 | 4 | 0001193125-26-290586 |
| May 29, 2026 | 8-K | 0001193125-26-248289 |
| May 28, 2026 | 3 | 0001193125-26-245915 |
| May 28, 2026 | 4 | 0001193125-26-245918 |
| May 14, 2026 | 10-Q | 0001193125-26-222885 |
| May 14, 2026 | 8-K | 0001193125-26-222879 |
| Mar 20, 2026 | 10-K/A | 0001193125-26-117604 |
| Feb 12, 2026 | 10-Q | 0001193125-26-047737 |
| Feb 12, 2026 | 8-K | 0001193125-26-047742 |
| Feb 11, 2026 | 424B3 | 0001193125-26-044984 |
| Feb 10, 2026 | EFFECT | 9999999995-26-000516 |
| Jan 30, 2026 | S-3 | 0001193125-26-031753 |
| Jan 29, 2026 | SCHEDULE 13G/A | 0000038777-26-000024 |
| Jan 26, 2026 | 4 | 0001012975-26-000082 |
| Dec 29, 2025 | 4 | 0000899140-25-001479 |
| Dec 22, 2025 | 4 | 0000899140-25-001459 |
| Dec 8, 2025 | SCHEDULE 13G/A | 0001274173-25-000332 |
| Dec 3, 2025 | 4 | 0001012975-25-000848 |
| Dec 3, 2025 | 4 | 0001012975-25-000851 |
| Dec 3, 2025 | SCHEDULE 13G | 0001346824-25-000066 |
| Dec 3, 2025 | 4 | 0001012975-25-000850 |
| Dec 3, 2025 | 4 | 0001012975-25-000847 |
| Dec 3, 2025 | 4 | 0001012975-25-000849 |
| Dec 2, 2025 | 8-K | 0001193125-25-305475 |
| Nov 20, 2025 | 4 | 0001012975-25-000813 |